SHA — a global brand with destinations in Spain, Mexico, and planned expansion to the UAE — has established a Scientific Advisory Board. This venture comprises internationally recognized experts, including Dr. Jessica Shepherd in women's health and longevity, Dr. Darshan Shah in longevity and preventive health, Professor Emiliano Santarnecchi in cognitive neurology and brain stimulation from Harvard Medical School, stem cell scientist Christian Drapeau, and cardiologist Dr. Guillermo Torre-Amione from TecSalud.
SHA’s Scientific Advisory Board will oversee protocol validation, program innovation, and research alignment across areas such as executive health, regenerative medicine, cognitive performance, hormonal health, gut function, and metabolic optimization. Since the longevity and health optimization field is notoriously crowded with contradictory advice, unproven supplements, and clinics that make grand promises without scientific rigor, an expert-led initiative such as the Scientific Advisory Board will offer some clarity and peace of mind.
By assembling a board of this caliber, SHA signals that its method is not based on trends or pseudoscience but on peer-reviewed expertise and clinical experience.
Longevity-Focused Advisory Boards
SHA Establishes a Scientific Advisory Board
Trend Themes
-
Evidence-backed Longevity Programs — A movement toward clinically validated longevity protocols that replace anecdotal regimens with peer-reviewed, reproducible interventions and standardized outcome metrics.
-
Multidisciplinary Scientific Boards — Cross-specialty advisory panels combining cardiology, cognitive neurology, endocrinology, and stem cell science to align protocols with rigorous translational research and regulatory expectations.
-
Personalized Regenerative Protocols — Tailored combinations of regenerative therapies, metabolic optimization, and cognitive stimulation informed by individual biomarkers and longitudinal monitoring.
Industry Implications
-
Luxury Wellness Hospitality — High-end resort brands positioned as clinical-grade longevity destinations offering validated medical programs alongside premium hospitality services.
-
Clinical Research Partnerships — Contract research ecosystems that integrate boutique wellness providers with academic centers to generate publishable evidence and accelerate translational validation.
-
Health Technology Platforms — Digital platforms aggregating biomarker data, protocol libraries, and telemedicine to support personalized longevity pathways and centralized outcome tracking.